Search research articles
Contact Us
Filters
Showing results (61-70 of 124) with videos related to
Page
of 13
Sort By:
The Lancet. Oncology
|
September 1, 2005
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial
Frank Berthold, Joachim Boos, Stefan Burdach, et al.
Cancer Letters
|
July 19, 2005
The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives
Wendy B London, Luca Boni, Thorsten Simon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
Heterogeneity of the MYCN oncogene in neuroblastoma
Jessica Theissen, Marc Boensch, Ruediger Spitz, et al.
Genes, Chromosomes & Cancer
|
April 17, 2014
Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma
Jessica Theissen, Andre Oberthuer, Anja Hombach, et al.
Pediatric Blood & Cancer
|
April 7, 2021
Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplification
Frank Berthold, Carolina Rosswog, Holger Christiansen, et al.
Pediatric Blood & Cancer
|
December 30, 2025
RT-PCR-Based Detection of Bone Marrow Involvement in Ewing Sarcoma: Diagnostic Validity and Prognostic Relevance
Thanh Pham, Andreas Ranft, Victor Rechl, et al.
Neoplasia (New York, N.Y.)
|
November 2, 2017
Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment
Carolina Rosswog, Rene Schmidt, André Oberthuer, et al.
Cancers
|
January 8, 2023
Epidemiology and Characteristics of Gastric Carcinoma in Childhood-An Analysis of Data from Population-Based and Clinical Cancer Registries
Michael Abele, Lisa Grabner, Tabea Blessing, et al.
Cancer Medicine
|
August 20, 2025
Anthracycline-Induced Cardiomyopathy After Nephro-/Neuroblastoma in Childhood: The Importance of Cardiological Reference Assessment
Kristina Kleen, Judith Gebauer, Claudia Spix, et al.
Journal of Clinical Medicine
|
October 14, 2023
Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse
Tim Flaadt, Martin Ebinger, Malin Schreiber, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 124) with videos related to
Sort By:
Page
of 13
The Lancet. Oncology
|
September 1, 2005
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial
Frank Berthold, Joachim Boos, Stefan Burdach, et al.
Cancer Letters
|
July 19, 2005
The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives
Wendy B London, Luca Boni, Thorsten Simon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
Heterogeneity of the MYCN oncogene in neuroblastoma
Jessica Theissen, Marc Boensch, Ruediger Spitz, et al.
Genes, Chromosomes & Cancer
|
April 17, 2014
Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma
Jessica Theissen, Andre Oberthuer, Anja Hombach, et al.
Pediatric Blood & Cancer
|
April 7, 2021
Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplification
Frank Berthold, Carolina Rosswog, Holger Christiansen, et al.
Pediatric Blood & Cancer
|
December 30, 2025
RT-PCR-Based Detection of Bone Marrow Involvement in Ewing Sarcoma: Diagnostic Validity and Prognostic Relevance
Thanh Pham, Andreas Ranft, Victor Rechl, et al.
Neoplasia (New York, N.Y.)
|
November 2, 2017
Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment
Carolina Rosswog, Rene Schmidt, André Oberthuer, et al.
Cancers
|
January 8, 2023
Epidemiology and Characteristics of Gastric Carcinoma in Childhood-An Analysis of Data from Population-Based and Clinical Cancer Registries
Michael Abele, Lisa Grabner, Tabea Blessing, et al.
Cancer Medicine
|
August 20, 2025
Anthracycline-Induced Cardiomyopathy After Nephro-/Neuroblastoma in Childhood: The Importance of Cardiological Reference Assessment
Kristina Kleen, Judith Gebauer, Claudia Spix, et al.
Journal of Clinical Medicine
|
October 14, 2023
Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse
Tim Flaadt, Martin Ebinger, Malin Schreiber, et al.
Page
of 13